Table 1. Clinical and biochemical characteristics of patients with insulinoma, nesidioblastosis, and insulin autoimmune syndrome.

Values are presented as median (range) or number (%).

IAS, insulin autoimmune syndrome; OGTT, oral glucose tolerance test.

^aNumber of patients who developed autonomic hypoglycemic symptoms (e.g., sweating, palpitation, anxiety, hunger, nausea, and paresthesia), ^bNumber of patients who developed neuroglycopenic hypoglycemic symptoms (e.g., loss of consciousness, disorientation, fatigue, seizure, hypersomnia, blurred vision, and change in behavior), ^cNumber of patients who developed hypoglycemia on 72-hour fasting test/total number of patients who received a 72-hour fasting test, ^dNumber of patients who developed hypoglycemia during OGTT/total number of patients who underwent OGTT, ^eStatistically significant development of hypoglycemia on 72-hour fasting test.